Basic Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Sep 7, 2020; 26(33): 4945-4959
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4945
Figure 5
Figure 5 Immunohistochemical staining of ZO-1 and occludin. Expressions of ZO-1 and occludin were higher in resveratrol treatment than in the dextran sulfate sodium group and 5-aminosalicylic acid treated group. Negative control: antibody was replaced by phosphate buffer saline. DSS: Dextran sulfate sodium; 5-ASA: 5-aminosalicylic acid; RES: Resveratrol.